Ivoclar Vivadent AG   Report issue

For profit Phase 4
Founded: Schaan Liechtenstein (1923)
Status: No NME R&D (1923)

Organization Overview

First Clinical Trial
2017
NCT02202304
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Ivoclar Vivadent AG

Active Ingredients

Drugs in Phase 4 Trials (2)

chlorhexidine (hibitane) (1 trial)

thymol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Periodontal Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2